Simple and portable test kits for use in a wide range of settings
New Product Lines - EU commission registered
COVID-19 Rapid Antibody Test Kit CE
A single use lateral flow immunoassay rapid test intended for qualitative detection and differentiation of anti-SARS-CoV-2 IgG and IgM antibodies in human serum and plasma or whole blood containing EDTA, heparin or citrate anti-coagulants.
This rapid test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. Best used 10-14 days after coronavirus symptoms and may take up to 30 days to identify the antibodies.
€150.00 inc VAT (30 tests @ €5 each)
COVID-19 Rapid Antigen Test Kit CE
A lateral flow immunoassay for the qualitative detection of SARS-CoV-2 virus in nasal, nasopharyngeal (NP), or oropharyngeal (throat) swab specimens from individuals who are suspected of COVID-19. Presence of SARS-CoV-2 virus can be detected within the first week of the onset of symptoms.
The OnSite COVID-19 Antigen Self Test is a single-use lateral flow immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasal swab specimens from individuals suspected of COVID-19. The test is designed for use with self-collected samples within the first 7 days post-onset of symptoms, as an aid in identifying SARS-CoV-2 infection.
From €3.50 inc VAT (1, 2 & 5 tests per kit)
More from CTK Biotech
Rapid Test Reader
The new and improved RTR-1 uses an image processing method. During measurement, the lateral flow device is captured using a 5-mega pixel camera and the picture is analyzed using image processing algorithms for identification of either presence or absence of test line bands or test line band intensity levels
